Triamcinolone
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ARISTOCORT | — | 1957-12-03 | fda.gov ↗ |
Trials 92 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT04126824 | Jan 2022 → Aug 2026 overdue | adenomyosis, uterine benign neoplasm | University of California, Los Angeles | Active not recruiting | No outcome recorded |
| Phase 0 | NCT03729310 | Mar → May 2020 | chronic rhinosinusitis | Weill Medical College of Cornell University | Withdrawn | No outcome recorded |
| Phase 13 trials | ||||||
| Phase 1 | NCT06362226 | Jun 2026 | disorder of orbital region | Virginia Commonwealth University | Withdrawn | No outcome recorded |
| Phase 1 | NCT00211419 | — | age-related macular degeneration | Manhattan Eye, Ear & Throat Hospital | Completed | No outcome recorded |
| Phase 1 | NCT00893854 | — | cystoid macular edema, uveitis | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT01222871 | Jul 2010 → Jul 2012 | nasal cavity polyp | Steward St. Elizabeth's Medical Center of Boston, Inc. | Terminated | No outcome recorded |
| Phase 1/2 | NCT00849537 | Apr 2008 → Apr 2009 | diabetic retinopathy | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 27 trials | ||||||
| Phase 2 | NCT06840561 | Nov 2021 → Dec 2024 | esophageal cancer | Sun Yat-sen University Cancer Center | Completed | No outcome recorded |
| Phase 2 | NCT03115567 | Feb 2017 → Apr 2020 | acneiform dermatitis | Northwestern University | Terminated | No outcome recorded |
| Phase 2 | NCT00701233 | Jun 2012 → Oct 2018 | carpal tunnel syndrome | University of Minnesota | Withdrawn | No outcome recorded |
| Phase 2 | NCT00597766 | Dec 2007 → Feb 2012 | arthropathy | MetroHealth Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT00370630 | Aug 2006 → Feb 2007 | retinal vascular disorder | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 2 | NCT00370266 | Feb 2003 → Oct 2007 | occlusion of tributary of retinal vein | Shahid Beheshti University of Medical Sciences | Completed | No outcome recorded |
| Phase 2 | NCT00021294 | May 2001 → Jun 2002 | precancerous condition, skin cancer | University of Arizona | Completed | No outcome recorded |
| Phase 2/37 trials | ||||||
| Phase 2/3 | NCT07445191 | Mar → Jun 2026 overdue | temporomandibular joint disorder | Cairo University | Not yet recruiting | No outcome recorded |
| Phase 2/3 | NCT02191748 | Sep 2014 → Jan 2018 | vitiligo | Rutgers, The State University of New Jersey | Terminated | No outcome recorded |
| Phase 2/3 | NCT00717652 | Jul 2008 | hyperpigmentation of the skin | Azidus Brasil | Suspended | No outcome recorded |
| Phase 2/3 | NCT00930189 | Apr 2006 | choroidal neovascularization | Asociación para Evitar la Ceguera en México | Withdrawn | No outcome recorded |
| Phase 2/3 | NCT00148330 | May 2005 → Jul 2008 | diabetic macular edema | University of Sydney | Completed | No outcome recorded |
| Phase 2/3 | NCT00148265 | Apr 2005 → May 2009 | diabetic macular edema | University of Sydney | Completed | No outcome recorded |
| Phase 2/3 | NCT00167518 | Mar 2002 → Apr 2005 | diabetic macular edema | University of Sydney | Completed | No outcome recorded |
| Phase 312 trials | ||||||
| Phase 3 | NCT07228104 | May 2026 → Jan 2031 expected | idiopathic subglottic stenosis | Johns Hopkins University | Recruiting | No outcome recorded |
| Phase 3 | NCT06288685 | Oct 2023 → Jan 2024 | arthropathy | Police General Hospital, Thailand | Completed | No outcome recorded |
| Phase 3 | NCT03958344 | Jan 2022 → Jun 2024 | orbital pseudotumor | Iran University of Medical Sciences | Unknown | No outcome recorded |
| Phase 3 | NCT04094298 | Jul 2019 → Oct 2024 overdue | rotator cuff syndrome, shoulder impingement syndrome, tendinitis | Northwell Health | Active not recruiting | No outcome recorded |
| Phase 3 | NCT03616340 | Aug 2018 → Aug 2019 | osteoarthritis, knee, rotator cuff syndrome, shoulder impingement syndrome | OSF Healthcare System | Unknown | No outcome recorded |
| Phase 3 | NCT03317015 | Nov 2016 → Jul 2017 | allergic rhinitis | Sanofi | Completed | No outcome recorded |
| Phase 3 | NCT02556424 | Jan 2016 → Feb 2021 | macular retinal edema | Nantes University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT01318590 | Nov 2011 → Jun 2019 | chronic pancreatitis | University of Montreal Hospital Centre (CHUM) | Terminated | No outcome recorded |
| Phase 3 | NCT00997191 | Oct 2009 → Nov 2011 | diabetic macular edema | University of Sao Paulo | Completed | No outcome recorded |
| Phase 3 | NCT00658736 | Mar 2008 → Jan 2011 | chronic pancreatitis | The Cleveland Clinic | Completed | No outcome recorded |
| Phase 3 | NCT00806169 | Apr 2006 → Oct 2008 | diabetic retinopathy, macular retinal edema | Johann Wolfgang Goethe University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT00370422 | Nov 2005 → Sep 2006 | diabetic macular edema | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 432 trials | ||||||
| Phase 4 | NCT07352566 | Aug 2026 → Jun 2030 expected | atopic eczema, psoriasis | University of California, San Francisco | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07494136 | May 2026 → May 2027 expected | radiculopathy, sciatica | University of Miami | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07276802 | Apr → Dec 2026 expected | cataract | Research Insight LLC | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07508098 | Jul 2025 → Jan 2026 | hyperpigmentation of the skin | Pak Emirates Military Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05364099 | Nov 2023 → Jan 2024 | chronic pain syndrome | University of Miami | Withdrawn | No outcome recorded |
| Phase 4 | NCT05845125 | May 2023 → May 2024 | frozen shoulder | Claire Bourgeois | Terminated | No outcome recorded |
| Phase 4 | NCT05997238 | Apr 2023 → Feb 2024 | osteoarthritis, knee | Peking University Third Hospital | Completed | No outcome recorded |
| Phase 4 | NCT05844930 | Jan 2023 → Feb 2025 | frozen shoulder | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 4 | NCT04687930 | Dec 2020 → Feb 2021 | juvenile idiopathic arthritis, osteoarthritis, knee | Sohag University | Completed | No outcome recorded |
| Phase 4 | NCT04524897 | Dec 2020 → Oct 2021 | — | Assiut University | Unknown | No outcome recorded |
| Phase 4 | NCT04278833 | Sep 2020 → May 2021 | disease of the tendon, osteoarthritis, shoulder impingement syndrome | Stanford University | Terminated | No outcome recorded |
| Phase 4 | NCT05220527 | Aug 2020 → Jul 2022 | osteoarthritis, knee | Taipei Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT04361513 | Apr → Jul 2020 | arthropathy | Sohag University | Completed | No outcome recorded |
| Phase 4 | NCT05660694 | Jan 2020 → Sep 2021 | neoplasm, oral submucous fibrosis | Altamash Institute of Dental Medicine | Completed | No outcome recorded |
| Phase 4 | NCT03797872 | Apr 2019 → Jul 2020 | psoriatic arthritis | University of Oxford | Completed | No outcome recorded |
| Phase 4 | NCT03982862 | Jul 2018 → Jun 2019 | keloid | Kaohsiung Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT03901768 | Apr 2018 → Jan 2020 | — | The University of Hong Kong | Unknown | No outcome recorded |
| Phase 4 | NCT03361176 | Mar → Oct 2018 | obesity disorder | Goldman, Butterwick, Fitzpatrick and Groff | Completed | No outcome recorded |
| Phase 4 | NCT03407027 | Nov 2017 → Apr 2019 | — | Hospital de Braga | Unknown | No outcome recorded |
| Phase 4 | NCT03777891 | Jun 2017 | reactive cutaneous fibrous lesion | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT02949466 | Oct 2016 → Jul 2017 | — | Taipei Medical University | Unknown | No outcome recorded |
| Phase 4 | NCT02748395 | May → Dec 2016 | anterior cutaneous nerve entrapment syndrome | Temple University | Withdrawn | No outcome recorded |
| Phase 4 | NCT02680301 | Mar 2016 → Mar 2017 | atopic eczema | Seton Healthcare Family | Completed | No outcome recorded |
| Phase 4 | NCT02317276 | Dec 2014 → Apr 2017 | atopic eczema | University of California, San Francisco | Terminated | No outcome recorded |
| Phase 4 | NCT01995045 | Jul 2012 → Dec 2015 | proliferative vitreoretinopathy, retinal detachment, retinoschisis | Emory University | Completed | No outcome recorded |
| Phase 4 | NCT01599273 | May 2012 → Aug 2014 | disease of orbital part of eye adnexa | Yonsei University | Completed | No outcome recorded |
| Phase 4 | NCT01420471 | Sep 2011 → May 2012 | sinusitis | St. Paul's Hospital, Canada | Completed | No outcome recorded |
| Phase 4 | NCT01898806 | Sep 2011 → Jan 2018 | alopecia areata | Columbia University | Terminated | No outcome recorded |
| Phase 4 | NCT01335321 | Mar → Nov 2011 | osteoarthritis | University of Sao Paulo General Hospital | Completed | No outcome recorded |
| Phase 4 | NCT00826462 | Mar 2009 → Jun 2013 | epicondylitis | University of Oslo | Completed | No outcome recorded |
| Phase 4 | NCT02049879 | Nov 2008 → Aug 2012 | osteoarthritis, knee | Laval University | Completed | No outcome recorded |
| Phase 4 | NCT00566761 | Jun 2007 | central retinal vein occlusion, macular retinal edema | Asociación para Evitar la Ceguera en México | Terminated | No outcome recorded |
| Phase not applicable27 trials | ||||||
| — | NCT07591233 | Jun 2026 → Mar 2027 expected | gallbladder disorder | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT07603921 | Jun 2026 → May 2027 expected | — | Beijing Tiantan Hospital | Recruiting | No outcome recorded |
| — | NCT05526898 | Oct 2024 → Dec 2025 | osteoarthritis, knee | Syntr Health Technologies, Inc. | Unknown | No outcome recorded |
| — | NCT06004882 | Aug 2023 → Jan 2027 expected | chronic pain syndrome | M.D. Anderson Cancer Center | Recruiting | No outcome recorded |
| — | NCT06170593 | Nov 2022 → Jan 2023 | acne | ACOM Labs | Completed | No outcome recorded |
| — | NCT05248139 | Oct 2022 → Feb 2023 | cataract, ocular hypertension | Visualiza | Unknown | No outcome recorded |
| — | NCT05738759 | May 2022 → Jul 2024 | lumbar disk disease | Queen Savang Vadhana Memorial Hospital, Thailand | Unknown | No outcome recorded |
| — | NCT06955455 | Jan 2022 → Oct 2024 | Bell's palsy | Tishreen University Hospital | Completed | No outcome recorded |
| — | NCT05381558 | Apr 2021 → Sep 2022 | flatfoot | Assiut University | Unknown | No outcome recorded |
| — | NCT04014244 | Mar 2021 → Mar 2022 | carpal tunnel syndrome | University Medical Centre Ljubljana | Unknown | No outcome recorded |
| — | NCT06228911 | Jan 2020 → Sep 2023 | osteoarthritis, knee, type 2 diabetes mellitus | Syrian Private University | Completed | No outcome recorded |
| — | NCT04165512 | Jan → Mar 2020 | lymphedema | Marmara University | Unknown | No outcome recorded |
| — | NCT03678038 | Sep 2018 → Jan 2021 | frozen shoulder | Taipei Veterans General Hospital, Taiwan | Completed | No outcome recorded |
| — | NCT03871465 | Aug 2018 → Jul 2020 | bursitis, shoulder impingement syndrome | Shin Kong Wu Ho-Su Memorial Hospital | Completed | No outcome recorded |
| — | NCT04235478 | Dec 2017 → Feb 2020 | cervical disk degenerative disorder, neuropathy, painful | Marmara University | Unknown | No outcome recorded |
| — | NCT03039608 | Feb 2017 → Jul 2018 | — | Shanghai Zhongshan Hospital | Completed | No outcome recorded |
| — | NCT02704507 | Jun 2015 → Jan 2016 | acne | Carilion Clinic | Unknown | No outcome recorded |
| — | NCT02399800 | Dec 2014 → Feb 2018 | chronic pancreatitis | University of Southern California | Terminated | No outcome recorded |
| — | NCT02653963 | Sep 2014 → Apr 2016 | glaucoma | Shahid Beheshti University of Medical Sciences | Completed | No outcome recorded |
| — | NCT02702206 | Aug 2014 → Oct 2016 | bursitis | Shin Kong Wu Ho-Su Memorial Hospital | Completed | No outcome recorded |
| — | NCT02577991 | Feb 2014 → Jun 2017 | — | Northwestern University | Completed | No outcome recorded |
| — | NCT06493656 | Dec 2013 → Nov 2015 | frozen shoulder | Chuncheon Sacred Heart Hospital | Completed | No outcome recorded |
| — | NCT01280214 | Feb 2011 → Feb 2013 | thyroid gland disorder | HaEmek Medical Center, Israel | Unknown | No outcome recorded |
| — | NCT00478764 | Mar 2006 → Apr 2007 | cataract | Dean Health System | Completed | No outcome recorded |
| — | NCT00640575 | Mar 2005 → Oct 2006 | rotator cuff syndrome | Ullevaal University Hospital | Completed | No outcome recorded |
| — | NCT00441662 | Nov 2004 → May 2007 | melanoma | Wills Eye | Completed | No outcome recorded |
| — | NCT00668239 | Sep 2004 → Apr 2006 | diabetic macular edema | Hospital de Clinicas de Porto Alegre | Completed | No outcome recorded |
Also used as a comparator or background therapy in 110 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 03 trials | ||||||
| Phase 0 | NCT06032039 Comparator | Oct 2023 → Oct 2024 | osteoarthritis, knee | The University of The West Indies | Unknown | No outcome recorded |
| Phase 0 | NCT05349448 Comparator | Mar → Nov 2022 | neuropathy, painful | Minia University | Unknown | No outcome recorded |
| Phase 0 | NCT04036188 Background | Oct 2019 → Dec 2026 expected | psoriasis | Wright State University | Recruiting | No outcome recorded |
| Phase 15 trials | ||||||
| Phase 1 | NCT06504160 Background | May 2025 → Dec 2026 expected | atopic eczema | National Institute of Allergy and Infectious Diseases (NIAID) | Recruiting | No outcome recorded |
| Phase 1 | NCT04929951 Comparator | Jul 2022 → Dec 2027 expected | osteoarthritis | Stanford University | Recruiting | No outcome recorded |
| Phase 1 | NCT03877679 Comparator | May 2019 → May 2020 | lichen planus, oral | Cairo University | Unknown | No outcome recorded |
| Phase 1 | NCT01920373 Comparator | Nov 2013 | osteoarthritis | Kaiser Permanente | Withdrawn | No outcome recorded |
| Phase 1 | NCT00371111 Comparator | Aug 2006 → May 2008 | cystoid macular edema | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01330524 Comparator | Jan → Nov 2010 | non-arteritic anterior ischemic optic neuropathy | Shahid Beheshti University of Medical Sciences | Unknown | No outcome recorded |
| Phase 213 trials | ||||||
| Phase 2 | NCT07680504 Background | Jun 2026 → Jun 2029 expected | frozen shoulder | Nantes University Hospital | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07596628 Background | Jun 2026 → Dec 2027 expected | keloid formation | Ong Kim Yao | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07168148 Background | Nov 2025 → Mar 2026 | chronic rhinitis | Washington University School of Medicine | Terminated | No outcome recorded |
| Phase 2 | NCT06994520 Comparator | May 2025 → May 2026 overdue | atopic eczema, prurigo, prurigo nodularis | Khon Kaen University | Active not recruiting | No outcome recorded |
| Phase 2 | NCT05811351 Background | Mar 2023 → Feb 2026 | diffuse secondary choroid atrophy | Janssen Research & Development, LLC | Completed | No outcome recorded |
| Phase 2 | NCT07370233 Comparator | Feb 2023 → Mar 2025 | vertebral column disorder | Benha University | Completed | No outcome recorded |
| Phase 2 | NCT04117919 Background | Oct → Dec 2019 | psoriasis | China Medical University Hospital | Unknown | No outcome recorded |
| Phase 2 | NCT03380026 Comparator | Dec 2017 → Aug 2020 | folliculotropic mycosis fungoides, granulomatous slack skin disease, mycosis fungoides | Rochester Skin Lymphoma Medical Group, PLLC | Completed | No outcome recorded |
| Phase 2 | NCT03011892 Comparator | Jan 2017 → Jan 2018 | atopic eczema | Incyte Corporation | Completed | No outcome recorded |
| Phase 2 | NCT02576938 Background | Feb 2016 → Feb 2017 | atopic eczema | Eli Lilly and Company | Completed | No outcome recorded |
| Phase 2 | NCT01906944 Comparator | Jan 2012 → Aug 2019 | — | Mayo Clinic | Completed | No outcome recorded |
| Phase 2 | NCT00846625 Comparator | Nov 2009 → Aug 2011 | macular retinal edema, uveitis | University of Utah | Withdrawn | No outcome recorded |
| Phase 2 | NCT00623766 Background | Jul 2008 → Sep 2009 | melanoma | Bristol-Myers Squibb | Completed | No outcome recorded |
| Phase 2/35 trials | ||||||
| Phase 2/3 | NCT06681194 Comparator | Jun 2025 → Dec 2028 expected | — | Francesco Egro | Not yet recruiting | No outcome recorded |
| Phase 2/3 | NCT04480775 Comparator | Jul → Dec 2020 | — | ghada fouad | Completed | No outcome recorded |
| Phase 2/3 | NCT04460001 Comparator | May 2019 → Aug 2021 | — | Assiut University | Unknown | No outcome recorded |
| Phase 2/3 | NCT04441112 Comparator | May 2018 → Aug 2019 | osteoarthritis, hip, osteoarthritis, knee | Saint Alphonsus Regional Medical Center | Completed | No outcome recorded |
| Phase 2/3 | NCT02967302 Comparator | Aug 2015 → Dec 2021 | osteoarthritis, knee | Hildrun Haibel | Unknown | No outcome recorded |
| Phase 312 trials | ||||||
| Phase 3 | NCT04990128 Comparator | Jun 2026 → Jul 2027 expected | osteoarthritis, hip | The Cleveland Clinic | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT07336368 Background | Jun 2026 → Jun 2027 expected | keloid | Sonal Choudhary | Recruiting | No outcome recorded |
| Phase 3 | NCT05992883 Comparator | Jul 2023 → Dec 2026 expected | osteoarthritis, hand | Mayo Clinic | Recruiting | No outcome recorded |
| Phase 3 | NCT04775225 Comparator | Jan → Apr 2021 | juvenile idiopathic arthritis | Sohag University | Completed | No outcome recorded |
| Phase 3 | NCT04253457 Background | Feb 2020 → Jan 2025 | carpal tunnel syndrome, de Quervain disease, trigger thumb | University Hospital Plymouth NHS Trust | Suspended | No outcome recorded |
| Phase 3 | NCT05271058 Comparator | Jun 2019 → Jun 2020 | corneal edema | Cairo University | Completed | No outcome recorded |
| Phase 3 | NCT03467919 Comparator | Apr 2018 → Oct 2024 | osteoarthritis, knee | Stanford University | Completed | No outcome recorded |
| Phase 3 | NCT02823236 Comparator | Oct 2016 → Dec 2019 | keloid | Centro Dermatológico Dr. Ladislao de la Pascua | Unknown | No outcome recorded |
| Phase 3 | NCT00780780 Comparator | Jul 2007 → Aug 2008 | diabetic macular edema | Federal University of São Paulo | Completed | No outcome recorded |
| Phase 3 | NCT00398866 Comparator | Aug 2006 → Mar 2013 | osteoarthritis | Hospital for Special Surgery, New York | Completed | No outcome recorded |
| Phase 3 | NCT00805064 Comparator | Jan 2006 → Dec 2007 | retinal vein occlusion | Johann Wolfgang Goethe University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT00000569 Comparator | Sep 1993 → May 1999 | chronic obstructive pulmonary disease | University of Minnesota | Completed | No outcome recorded |
| Phase 433 trials | ||||||
| Phase 4 | NCT07278323 Background | Jan → Dec 2026 expected | frozen shoulder | University of California, San Francisco | Recruiting | No outcome recorded |
| Phase 4 | NCT07131813 Comparator | Oct 2025 → Jan 2027 expected | lichen planus, oral | All India Institute of Medical Sciences, Bhubaneswar | Recruiting | No outcome recorded |
| Phase 4 | NCT06905860 Comparator | Jun 2025 → Jun 2027 expected | osteoarthritis, knee | Federal University of São Paulo | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT05977985 Comparator | Aug 2023 → Jul 2024 | frozen shoulder | University of Malaya | Unknown | No outcome recorded |
| Phase 4 | NCT05292339 Comparator | Jan 2023 → Jul 2027 expected | disease of the tendon, osteoarthritis | Emory University | Recruiting | No outcome recorded |
| Phase 4 | NCT05792111 Background | Oct 2022 → Dec 2023 | myofascial pain syndrome | Abant Izzet Baysal University | Unknown | No outcome recorded |
| Phase 4 | NCT05278858 Background | Mar 2022 → Jun 2023 | alopecia areata | University Hospitals Cleveland Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT04582669 Comparator | Jan → Oct 2022 | hidradenitis suppurativa | Montefiore Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT03832010 Comparator | Dec 2019 → Feb 2024 | atopic eczema | Johns Hopkins University | Completed | No outcome recorded |
| Phase 4 | NCT04143165 Comparator | Oct 2019 → Jan 2020 | ankylosing spondylitis | Sohag University | Completed | No outcome recorded |
| Phase 4 | NCT03704584 Comparator | May 2019 → Jan 2020 | tenosynovitis | Emory University | Terminated | No outcome recorded |
| Phase 4 | NCT03586687 Comparator | Jul 2018 → Sep 2021 | osteoarthritis | Milton S. Hershey Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT03382821 Comparator | Sep 2017 → Apr 2020 | radiculopathy | University of Utah | Completed | No outcome recorded |
| Phase 4 | NCT03241563 Comparator | Apr 2016 → Feb 2017 | — | Goldman, Butterwick, Fitzpatrick and Groff | Completed | No outcome recorded |
| Phase 4 | NCT03046108 Comparator | Jan 2016 → Aug 2018 | Morton neuroma | Complejo Hospitalario Universitario de Granada | Unknown | No outcome recorded |
| Phase 4 | NCT02655523 Comparator | Dec 2015 → Jun 2022 | headache disorder | Northwestern University | Withdrawn | No outcome recorded |
| Phase 4 | NCT03090698 Comparator | Sep 2015 → Apr 2017 | osteoarthritis, knee | Fluminense Federal University | Unknown | No outcome recorded |
| Phase 4 | NCT02451748 Background | Aug 2015 → Sep 2017 | rheumatoid arthritis | University of Illinois at Chicago | Completed | No outcome recorded |
| Phase 4 | NCT02398539 Comparator | Apr → Dec 2015 | pyogenic granuloma | Akron Children's Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT04743986 Comparator | Mar 2015 → Jun 2019 | rotator cuff syndrome | University of Calgary | Completed | No outcome recorded |
| Phase 4 | NCT03273036 Comparator | May 2014 → May 2015 | lumbar disk disease | Ramathibodi Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02155439 Comparator | May 2014 → Dec 2017 | keloid | Tampere University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02095197 Background | Mar 2014 → Jul 2016 | radiculopathy | Northwestern University | Completed | No outcome recorded |
| Phase 4 | NCT03641508 Comparator | Jan 2014 → Oct 2016 | trigger thumb | Ericka Lawler | Completed | No outcome recorded |
| Phase 4 | NCT02024724 Comparator | Nov 2013 → Mar 2016 | persistent idiopathic facial pain | Northwestern University | Completed | No outcome recorded |
| Phase 4 | NCT01801774 Comparator | May 2012 → Jul 2015 | ocular hypertension | Mahidol University | Unknown | No outcome recorded |
| Phase 4 | NCT05223244 Comparator | Oct 2011 → Apr 2019 | interstitial cystitis | Endeavor Health | Completed | No outcome recorded |
| Phase 4 | NCT01429870 Comparator | Aug 2011 → Aug 2016 | psoriasis | University of Zurich | Withdrawn | No outcome recorded |
| Phase 4 | NCT01703325 Comparator | Nov 2010 → Mar 2012 | psoriasis | Mahidol University | Completed | No outcome recorded |
| Phase 4 | NCT00737971 Comparator | Aug 2008 → Dec 2012 | diabetic macular edema | Rubens Belfort Jr. | Completed | No outcome recorded |
| Phase 4 | NCT00682539 Comparator | Oct 2007 → Jul 2014 | diabetic macular edema | Medical University of Vienna | Completed | No outcome recorded |
| Phase 4 | NCT00731289 Comparator | Jul 2003 → Dec 2005 | osteoarthritis | Philipps University Marburg | Completed | No outcome recorded |
| Phase 4 | NCT01295099 Comparator | — | keloid | Queen Mary University of London | Withdrawn | No outcome recorded |
| Phase not applicable38 trials | ||||||
| — | NCT07568015 Comparator | Jul 2026 → Nov 2027 expected | — | Brixton Biosciences, Inc. | Not yet recruiting | No outcome recorded |
| — | NCT07512219 Comparator | May → Nov 2026 expected | migraine disorder | Sohag University | Not yet recruiting | No outcome recorded |
| — | NCT06498180 Background | Dec 2024 → Dec 2027 expected | oral erosive lichen, periodontitis | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | Not yet recruiting | No outcome recorded |
| — | NCT06700109 Comparator | Nov 2024 → Feb 2027 expected | osteoarthritis, knee | Brixton Biosciences, Inc. | Active not recruiting | No outcome recorded |
| — | NCT06685081 Comparator | Jul → Oct 2024 | — | Menoufia University | Completed | No outcome recorded |
| — | NCT06653985 Background | May 2024 → Oct 2026 expected | osteoarthritis | ArthroBiologix Inc. | Recruiting | No outcome recorded |
| — | NCT06754033 Background | Feb → Aug 2024 overdue | coccygodynia | Superior University | Active not recruiting | No outcome recorded |
| — | NCT05818150 Comparator | Jan 2024 → Apr 2026 overdue | osteoarthritis, knee | Merit Medical Systems, Inc. | Active not recruiting | No outcome recorded |
| — | NCT05852808 Comparator | Oct 2023 → May 2024 | chronic pain syndrome, osteoarthritis, spine | Silvia Gomez Ordonez | Terminated | No outcome recorded |
| — | NCT06619080 Comparator | Apr 2023 → Jan 2024 | osteoarthritis, knee | Hospital Universitario Fundación Alcorcón | Completed | No outcome recorded |
| — | NCT07174167 Comparator | Apr 2023 → Feb 2024 | osteoarthritis, knee | Haydarpasa Numune Training and Research Hospital | Completed | No outcome recorded |
| — | NCT05818111 Background | Jan 2023 → Jan 2024 | frozen shoulder | Taipei Veterans General Hospital, Taiwan | Unknown | No outcome recorded |
| — | NCT05624866 Comparator | Oct 2022 → Nov 2023 | carpal tunnel syndrome | Assiut University | Unknown | No outcome recorded |
| — | NCT05408208 Comparator | May → Nov 2022 | psoriasis | Sohag University | Unknown | No outcome recorded |
| — | NCT04961281 Comparator | Jul 2021 → Jul 2022 | carpal tunnel syndrome, chronic pain syndrome | Assiut University | Completed | No outcome recorded |
| — | NCT04710719 Comparator | Feb 2021 → Jul 2022 | keloid | Our Lady of the Lake Hospital | Completed | No outcome recorded |
| — | NCT05464953 Comparator | Jan 2020 → Apr 2022 | diabetic macular edema | Al-Azhar University | Completed | No outcome recorded |
| — | NCT05234840 Comparator | Apr 2019 → May 2021 | — | Queen Savang Vadhana Memorial Hospital, Thailand | Completed | No outcome recorded |
| — | NCT04442633 Background | Apr → Aug 2019 | lichen planus | Hams Hamed Abdelrahman | Completed | No outcome recorded |
| — | NCT02986906 Comparator | Mar 2017 → Oct 2019 | ulnar neuropathy | Tri-Service General Hospital (TSGH) | Completed | No outcome recorded |
| — | NCT02990962 Comparator | Dec 2016 → Apr 2018 | carpal tunnel syndrome | Tri-Service General Hospital (TSGH) | Completed | No outcome recorded |
| — | NCT02242630 Comparator | Sep 2014 → Mar 2016 | bursitis | Keesler Air Force Base Medical Center | Completed | No outcome recorded |
| — | NCT02108496 Comparator | Jul 2014 → Jun 2021 | osteoarthritis | Active Implants | Completed | No outcome recorded |
| — | NCT02962518 Background | Jul 2014 → Oct 2016 | keloid formation | University of Ulm | Completed | No outcome recorded |
| — | NCT02136901 Comparator | Jun 2014 → Jun 2020 | osteoarthritis | Active Implants | Completed | No outcome recorded |
| — | NCT02084706 Background | Mar 2014 → Mar 2015 | arthropathy | Brigham and Women's Hospital | Completed | No outcome recorded |
| — | NCT02700906 Comparator | Jan 2014 → Dec 2015 | epicondylitis | Shin Kong Wu Ho-Su Memorial Hospital | Completed | No outcome recorded |
| — | NCT01830699 Comparator | Mar 2013 → Mar 2014 | bursitis | Keesler Air Force Base Medical Center | Completed | No outcome recorded |
| — | NCT02420041 Background | Oct 2012 → Mar 2014 | arthritis, sacroiliac | United States Naval Medical Center, San Diego | Completed | No outcome recorded |
| — | NCT01404364 Comparator | Jan → Dec 2010 | glaucoma, visual impairment and progressive phthisis bulbi | Hospital Governador Celso Ramos | Completed | No outcome recorded |
| — | NCT00928564 Comparator | Apr 2009 → Dec 2015 | levator syndrome | University of California, Irvine | Completed | No outcome recorded |
| — | NCT04058522 Background | Sep 2008 → Feb 2013 | shoulder impingement syndrome | South Eastern Health and Social Care Trust | Completed | No outcome recorded |
| — | NCT00757315 Comparator | Sep 2008 → Sep 2009 | acne keloid, scalp dermatosis, sycosis barbae | Henry Ford Health System | Unknown | No outcome recorded |
| — | NCT02343432 Background | Mar → Aug 2008 | — | Neslihan Uztüre | Completed | No outcome recorded |
| — | NCT00203294 Comparator | Jun 2005 → Jun 2006 | migraine disorder | Thomas Jefferson University | Completed | No outcome recorded |
| — | NCT00757016 Comparator | Oct 2004 → Nov 2007 | — | Sundsvall Hospital | Completed | No outcome recorded |
| — | NCT01544842 Comparator | Aug 2004 → Feb 2015 | lichen planus, oral | University of Oulu | Terminated | No outcome recorded |
| — | NCT01449448 Comparator | Sep 2000 → Sep 2005 | bursitis, shoulder impingement syndrome | Madigan Army Medical Center | Withdrawn | No outcome recorded |
Evidence & citations 30 cited values
Every value below carries the sentence it was read from. 204 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Triamcinolone | “Single injection of 20ml corticosteroid solution (1 ml triamcinolone 40 mg/ml + 19 ml saline 0.9%) into the rotator interval around the long head biceps tendon under ultrasound...” NCT05977985 ↗184“The cocktail, consists of triamcinolone 40 mg, marcaine 5 mg, and morphine 3 mg, is soaked in the gelfoam size 1x2 cm and applied on the epidura before removal of the endoscope.” NCT05738759 ↗ “Group A will receive one intra-articular injection of 2 ml of solution containing 1ml of 10mg/ml Triamcinolone suspended in 1 ml of 0.5% Bupivacaine solution per affected joint” NCT01920373 ↗ “Patients will receive an ultrasound-guided injection consisting of 3 ml hyaluronic acid (Durolane™) mixed with 40 mg triamcinolone (Kenalog™) into their hip joint.” NCT06653985 ↗ “EUS procedure with injection of 10 ml Bupivacaine 0.5% and 40 mg of Triamcinolone in the celiac plexus after administration of intravenous (IV) antibioprophylaxis” NCT01318590 ↗ “Control Group (corticosteroid alone) subjects will receive (40 mg/mL injection of Methylprednisolone acetate injectable suspension or 40 mg/mL triamcinolone) .” NCT03704584 ↗ “8ml of 0.5% bupivicaine, 1ml of 10mg/ml triamcinolone, 1ml of 8.4% sodium bicarbonate for a total volume of 10ml. Five ml will be used at each block site.” NCT00928564 ↗ “Advanced Touhy needle delivery of 80 mg triamcinolone and 1500 IU hyaluronidase into the epidural space to target inflammation and adhesions” NCT07370233 ↗ “The proposed study will compare the efficacy of Triamcinolone versus Ketorolac for intra-articular injection of the knee and shoulder” NCT03616340 ↗ “1% lidocaine hydrochloride (xylocaine AstraZeneca) 9 mL mixed with 1 mL of triamcinolone 40 milligrams (Kenacort Bristol Myers Squip)” NCT04143165 ↗ “GON block using 3-5 mL of local anesthetic, optionally combined with 20-40 mg triamcinolone ( Bilaterally )” NCT07512219 ↗ “Intra-articular injection of a corticosteroid, such as 40 mg of Triamcinolone (e.g. Aristocort or Kenalog).” NCT02108496 ↗ “Intra-articular injection of a corticosteroid, such as 40 mg of Triamcinolone (e.g. Aristocort or Kenalog).” NCT02136901 ↗ “a 5 mL combination of 1 mL of 40 mg/mL triamcinolone, 2 mL of 0.2% ropivacaine, and 2 mL of normal saline” NCT07278323 ↗ “A solution of triamcinolone 40 mg (Kenalog) mixed with 3 cc of 2% xylocaine without epinephrine.” NCT02049879 ↗ “triamcinolone (10mg/ml) 1 ml will be injected to the lateral epicondyle of the affected elbow.” NCT02700906 ↗ “under US guidance, 2ml triamcinolone (1ml/10mg), 0.5ml distilled water and 1ml 1% lidocaine” NCT02702206 ↗ “40 mg Triamcinolone with one mL 1% lidocaine injected once into Carpal Tunnel” NCT00701233 ↗ “sufficient quantity of Triamcinolone was put by a syringe over the whole scar” NCT03777891 ↗ “a solution of 10ml containing 40mg of Triamcinolone will be administered” NCT06905860 ↗ “Injection Doses: 2.5 mL of 0.5% bupivacaine + 20 mg of triamcinolone.” NCT06619080 ↗ “Intra-articular injection of corticosteroid (Triamcinolone 40mg).” NCT03467919 ↗ “Intra-articular injection of corticosteroid (Triamcinolone 40mg)” NCT04929951 ↗ “a 5-fluorouracil (5-FU) and Kenalog (triamcinolone) combination” NCT06362226 ↗ “Intra-articular injection of 80mg of triamcinolone” NCT04775225 ↗ “2 cc (40 mg/mL) triamcinolone intra-bursal once” NCT01830699 ↗ “40mg/ml triamcinolone in 2 ml 0.5% bupivicaine” NCT04743986 ↗ “Triamcinolone injections versus 5% dextrose” NCT04014244 ↗ “Triamcinolone in unguentum leniens 0.1%” NCT01429870 ↗ “intra-articular triamcinolone (TA) only” PMID 36197647 ↗ Oct 2022 “Triamcinolone or methylprednisolone” NCT05818150 ↗ “Triamcinolone 20 mg (1cc)” NCT05844930 ↗ “triamcinolone 40mg 4cc” NCT05818111 ↗ “Triamcinolone” NCT00757315 ↗ |
| Known as | Aristocort | “Intra-articular injection of a corticosteroid, such as 40 mg of Triamcinolone (e.g. Aristocort or Kenalog).” NCT02108496 ↗1“Intra-articular injection of a corticosteroid, such as 40 mg of Triamcinolone (e.g. Aristocort or Kenalog).” NCT02136901 ↗ |
| Known as | Formulated Triamcinolone | “Formulated Triamcinolone: is triamcinolone and sodium hyaluronate and chondroitin sulfate” NCT05464953 ↗ |
| Known as | FX006 | “The primary objective of this study is to assess the overall safety and general tolerability of extended release triamcinolone acetate (TA-ER/FX006) in patient with rotator...” NCT04094298 ↗ |
| Known as | IVT | “To evaluate the effect of three intravitreal injections of bevacizumab (IVB) alone or combined with triamcinolone (IVT) in the first injection for treatment of refractory...” PMID 17917738 ↗ Oct 2007 |
| Known as | Kenacort | “20 mg Kenacort + 1 ml Bupivacain (2.5 mg/ml) will be injected into the affected facet joints.” NCT05852808 ↗ |
| Known as | Kenacort - T (triamcinolone) | “Kenacort - T (triamcinolone)” NCT00826462 ↗ |
| Known as | Kenacort Bristol Myers Squip | “1% lidocaine hydrochloride (xylocaine AstraZeneca) 9 mL mixed with 1 mL of triamcinolone 40 milligrams (Kenacort Bristol Myers Squip)” NCT04143165 ↗ |
| Known as | KENACORT RETARD | “Intra-articular injection: injection of 2 mL of 1% lidocaine along the needle path and 1 mL of KENACORT RETARD® 40 mg.” NCT07680504 ↗1“injection of 2 mL of 1% lidocaine along the needle path and 1 mL of KENACORT RETARD® 40 mg.” NCT07680504 ↗ |
| Known as | Kenacort-A | “Received intracameral 2 mg/0.05 ml triamcinolone (TA) (Kenacort-A®; Bristol-Myers Squibb) at the end of phacoemulsification.” NCT05271058 ↗ |
| Known as | Kenalog | “Patients will receive an ultrasound-guided injection consisting of 3 ml hyaluronic acid (Durolane™) mixed with 40 mg triamcinolone (Kenalog™) into their hip joint.” NCT06653985 ↗7“Intra-articular injection of a corticosteroid, such as 40 mg of Triamcinolone (e.g. Aristocort or Kenalog).” NCT02136901 ↗ “Intra-articular injection of a corticosteroid, such as 40 mg of Triamcinolone (e.g. Aristocort or Kenalog).” NCT02108496 ↗ “A solution of triamcinolone 40 mg (Kenalog) mixed with 3 cc of 2% xylocaine without epinephrine.” NCT02049879 ↗ “a 5-fluorouracil (5-FU) and Kenalog (triamcinolone) combination” NCT06362226 ↗ “Intraoperative delivery of medication, Kenalog (Triamcinolone)” NCT05248139 ↗ “Kenalog (triamcinolone; corticosteroid injection)” NCT00398866 ↗ “Kenalog” NCT03641508 ↗ |
| Known as | Kenalog = Triamcinolone | “Kenalog = Triamcinolone” NCT00597766 ↗ |
| Known as | Lederspan, Meda AB, Solna, Sweden (Triamcinolone) | “Lederspan, Meda AB, Solna, Sweden (Triamcinolone)” NCT00757016 ↗ |
| Known as | Shincort | “Triamcinolone (Shincort) injection to rotator interval” NCT03678038 ↗ |
| Known as | TA-ER | “The primary objective of this study is to assess the overall safety and general tolerability of extended release triamcinolone acetate (TA-ER/FX006) in patient with rotator...” NCT04094298 ↗ |
| Known as | TAC | “DB: Triamcinolone (TAC) 0.1% BID/Vehicle Cream BID” NCT03011892 ↗1“Triamcinolone (TAC) 0.1% cream” NCT06994520 ↗ |
| Known as | Triamcenolone in orabase | “Triamcenolone in orabase” NCT03877679 ↗ |
| Known as | Triamcinolone (Kenalog) | “Triamcinolone (Kenalog)” NCT01830699 ↗ |
| Known as | Triamcinolone acetate | “The primary objective of this study is to assess the overall safety and general tolerability of extended release triamcinolone acetate (TA-ER/FX006) in patient with rotator...” NCT04094298 ↗12“Local blockade therapy with Betamethasone Sodium Phosphate Injection (containing 1.4mg Betamethasone equivalent), local use of 1% Triamcinolone Acetate Ointment” NCT06498180 ↗ “Ganglion Impar Block using Triamcinolone Acetate (40 mg) and Bupivacaine (0.25%) administered with a 22G Spinal Needle under Fluoroscopic Guidance).” NCT06754033 ↗ “4.7% N-acetylcysteine, 2% Hydroquinone and 0.1 % triamcinolone acetate twice daily for 8 weeks” NCT07508098 ↗ |
| Known as | Triamcinolone Acetonid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05408208 ↗ |
| Known as | Triamcinolone Acetonide | “Triamcinolone acetonide is a synthetic corticosteroid with a preventive effect on collagen synthesis, fibrosis, and chronic cicatrization that has been used for many years,...” NCT04524897 ↗2“A few years ago, however, only triamcinolone acetonide was available to ophthalmologists.” PMID 32041669 ↗ Feb 2020 “Triamcinolone Acetonide 40mg/mL” NCT03382821 ↗ |
| Known as | Triancil | “A Intraarticular injection of 6ml of Hylan GF-20 (Synvisc) + 1ml of triamcinolone (Triancil)” NCT01335321 ↗ |
| Known as | Triesence | “subconjunctival injection of triamcinolone 40mg/mL (Triesence) at the end of surgery” NCT07276802 ↗ |
| Known as | trigon depot | “blind injection of 40 mg of triamcinolone (trigon depot ®)” NCT03046108 ↗ |
| Known as | Volon A | “The intravitreal injection of triamcinolone (Volon A®) is performed in the operating room under sterile conditions at baseline.” NCT00682539 ↗ |
| Known as | Volon A10 | “one intraarticular injection of triamcinolone 1 ml (Volon A10®, 10mg triamcinolone acetonide, 10mg/ml)” NCT00731289 ↗ |
| Known as | XRG5029 | “triamcinolone XRG5029” NCT03317015 ↗ |
| Action | Inhibit | “The rationale for the use of corticosteroids in temporomandibular joint therapy is that they inhibit prostaglandin synthesis and decrease the activity of collagenase and other...” NCT01920373 ↗ |
| Modality | Other / unclassified | “Corticosteroid: Triamcinolone” NCT00623766 ↗ |
| Route | Topical | “Patients receive eflornithine (DFMO) topically and triamcinolone topically to forearms once daily.” NCT00021294 ↗ |